Header cover image

Mexican Pharmaceuticals & Biotech Potentially Undervalued Companies

UPDATED Dec 06, 2023

Companies with a Value score of at least 3, ordered by Value score

52 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
BMY *Bristol-Myers SquibbUS$868.881.4%-45.0%US$101.5bUS$1,117.16PE12.3xE11.4%4.6%
ARDX *ArdelyxUS$87.9537.3%n/aUS$1.2bUS$165.00PS8.9xE72.3%n/a
BAYN NBayer€595.00-22.0%-46.2%€31.8b€923.74PB1xE66.0%7.4%
ATOS *Atossa TherapeuticsUS$12.850.4%-4.8%US$92.1mUS$83.04PB0.9xE73.6%n/a
AMGN *AmgenUS$4,549.050%-17.1%US$144.2bUS$4,662.35PE19.1xE5.7%3.2%
NSTG *NanoString TechnologiesUS$29.320%-78.8%US$28.3mUS$250.26PE-0.2xE36.0%n/a
BCRX *BioCryst PharmaceuticalsUS$113.920%-57.8%US$1.1bUS$320.75PS3.3xE73.2%n/a
SOBI NSwedish Orphan Biovitrumkr567.340%0%kr64.7bkr746.39PE20.4xE15.6%n/a
GSK NGSKUK£629.00-0.2%n/aUK£58.7bUK£754.48PE9.7xE6.1%3.9%
ROG NRoche HoldingCHF5,020.916.5%-22.6%CHF201.3bCHF6,197.04PE18.1xE10.9%3.8%
SAN1 NSanofi€1,629.200%-11.7%€108.0b€1,993.70PE11.9xE7.0%4.1%
SNY NSanofi€813.921.7%-7.0%€108.0b€996.02PE11.9xE7.0%4.1%
AGIO *Agios PharmaceuticalsUS$432.080%-33.7%US$1.4bUS$612.41PS75.6xE13.7%n/a
ENDPQ NEndo InternationalUS$169.000%n/aUS$19.2mUS$2,068.54PE-0.006xn/an/a
ZLAB NZai LabUS$443.300%-26.6%US$2.8bUS$1,113.87PS10.6xE54.4%n/a
MRK1 NMerck KGaA€3,358.910%-8.8%€69.7b€4,326.25PE21xE8.7%1.4%
AZN1 NAstraZenecaUK£2,196.580%-5.5%UK£157.2bUK£2,851.88PE33.5xE19.4%2.2%
1093 NCSPC Pharmaceutical GroupHK$15.690%-27.0%HK$81.2bHK$22.49PE11.7xE2.6%4.2%
BGNE NBeiGeneUS$3,860.000%-41.9%US$18.8bUS$6,676.29PS12.1xE60.9%n/a
PHM1 NPharma Mar€1,608.380%0%€601.5m€2,866.23PE20.9xE26.7%2.0%
NVS NNovartisCHF1,754.600%n/aCHF174.5bCHF1,913.26PE24.5xE10.2%3.5%
4528 NOno PharmaceuticalJP¥341.690%-34.5%JP¥1.3tJP¥362.67PE9.9xE-5.0%3.1%
HCM NHUTCHMED (China)UK£819.630%0%UK£1.6bUK£1,868.97PS4.7xE53.8%n/a
ABCM NAbcamUS$292.380%-2.5%US$3.7bUS$360.48PS8.1xE37.2%0%
Page 1 of 3